Treatment | Concentration (μg/g) | Antioxidant activity (%) ± SE at time (day) | Average of ± SE | ||
---|---|---|---|---|---|
3 | 7 | 10 | |||
Control+ | 0.00 | 36.88 ± 0.58 | 17.84 ± 0.19 | 16.15 ± 0.26 | 23.62a ± 6.6 |
Control− | 0.00 | 38.12 ± 0.24 | 21.42 ± 0.66 | 18.90 ± 0.21 | 26.15b ± 6.03 |
Ch | 1000 | 43.76 ± 0.16 | 27.29 ± 0.29 | 23.67 ± 0.42 | 31.57c ± 6.18 |
2500 | 52.89 ± 0.24 | 28.62 ± 0.16 | 24.68 ± 0.32 | 35.40c ± 8.82 | |
Ch-AgNP1 | 1000 | 45.23 ± 0.11 | 42.95 ± 0.18 | 29.56 ± 0.33 | 39.25d ± 4.89 |
2500 | 55.83 ± 0.13 | 45.07 ± 0.44 | 30.39 ± 0.62 | 43.76d ± 7.37 | |
Ch-AgNP2 | 1000 | 47.84 ± 0.03 | 43.25 ± 0.36 | 31.31 ± 0.25 | 40.80e ± 4.93 |
2500 | 57.39 ± 0.29 | 47.19 ± 0.79 | 33.86 ± 0.13 | 46.14e ± 6.81 | |
Ch-AgNP3 | 1000 | 51.74 ± 0.37 | 45.29 ± 0.47 | 33.86 ± 0.37 | 43.63f ± 5.23 |
2500 | 60.69 ± 0.29 | 52.60 ± 0.22 | 35.58 ± 0.06 | 49.62f ± 7.40 | |
Mean | 47.1c | 34.23b | 26.08a | Between treatment for 1000 = 0.57 | |
LSD0.05 | Between time = 0.240 | Between treatment for 2500 = 0.63 |